Quick Take
- Narration: Del Hargis delivers a warm, grounded read that matches Rasmussen’s tone, measured, curious, occasionally wry, and never preachy.
- Themes: Cancer patient agency, alternative research pathways, skepticism alongside hope
- Mood: Candid and quietly urgent, with moments of dry humor
- Verdict: A genuine patient memoir that earns its credibility by refusing to oversell what it found.
I came to this one late on a Tuesday night, the kind of night where you’re not looking for anything heavy but end up somewhere unexpectedly real. A friend had mentioned fenbendazole in passing, something about a viral case study, a man named Joe Tippens, cancer forums buzzing with anecdotes. I was skeptical in the way that anyone with a literary-critical background tends to be skeptical of wellness narratives that travel through social media. Then I read the title again: Finding Fenbendazole: My Unexpected Path Through Cancer. The subtitle does a lot of work. “Unexpected path” is not the same as “miracle cure.” That distinction matters enormously, and Roger Rasmussen seems to know it.
Rasmussen was diagnosed with prostate cancer in 2019. His starting point is recognizable to anyone who has navigated a serious diagnosis: careful listening, weighing options, trying to make peace with decisions that feel both urgent and impossible to get right. Then he hears about Joe Tippens, a terminal small-cell lung cancer patient whose widely circulated account credited fenbendazole with his remarkable turnaround. Rasmussen follows that thread. He researches. He finds more accounts. He adds ivermectin to the conversation. And eventually he writes about it, with what reviewers have called both humor and rigor.
Where the Skepticism Lives
What separates this memoir from the noise in the alternative medicine space is the author’s explicit refusal to present himself as a convert with a gospel. Rasmussen describes going down a research rabbit hole, not emerging from a revelation. That distinction is textured throughout the book. He shares the available literature, acknowledges its limitations, and includes conversations with others on similar paths. One reviewer praised his “descriptions of fenben’s mechanisms of action” alongside his “review of the literature,” which signals that the science content is handled with more care than you might expect from a patient memoir of this length. The appendices covering fenbendazole and ivermectin research appear to be substantial rather than decorative.
The Human Document Beneath the Research
At three hours and thirty-five minutes, this is a short audiobook, and that brevity feels intentional. This is not a treatise. It is, as Rasmussen himself frames it, “a human guide, not a medical one.” The memoir sections are raw and unfiltered: the weight of a diagnosis at a particular moment in a life, the particular loneliness of sitting with uncertainty while researching things your oncologist has never heard of, the specific texture of hope that is not the same as denial. One reviewer who discovered the book after his own prostate cancer diagnosis at 67 mentioned listening to it twice and buying a second copy for his wife. That kind of response tells you something about the book’s emotional register: it finds readers at a moment when they need both information and company.
What Del Hargis Brings to It
Del Hargis narrates with a tone that matches the material well. There is a steadiness to his delivery, not clinical but careful, that suits a book walking a line between personal testimony and research synthesis. He handles the more technical passages without becoming a textbook reader, and brings enough warmth to the personal sections that you feel the person behind the pages. The production is clean, and at under four hours it is easy to listen to in a single sitting, which may be exactly how many of its readers encounter it: at a moment of diagnosis, looking for a coherent voice in a chaotic information landscape.
Who Should Listen and Who Should Skip
If you or someone close to you is navigating a cancer diagnosis and has encountered fenbendazole in online patient communities, this audiobook offers the most honest and well-organized account currently available in the format. It does not promise outcomes. It documents one patient’s investigation and experience. If you are looking for peer-reviewed clinical evidence or formal medical guidance, this is not that, and the author is upfront about it from the start. If you have no personal stake in the subject, the memoir sections are engaging but the book is clearly written for people for whom the stakes are real.
Frequently Asked Questions
Does Roger Rasmussen claim fenbendazole cured his prostate cancer?
No. The book explicitly frames itself as a personal journey and human document, not a miracle cure story. Rasmussen documents his research and experience without making definitive medical claims about outcomes.
How much of the audiobook covers the science versus the personal story?
The book blends both throughout. Reviewers note Rasmussen covers the mechanisms of action and reviews existing literature, but the memoir elements run throughout rather than being separated into distinct sections. The appendices add additional research context beyond the narrative.
Is this audiobook relevant if I have a cancer type other than prostate cancer?
The fenbendazole research and Joe Tippens case that sparked Rasmussen’s investigation are not prostate-specific, so the research sections have broader relevance. The personal narrative is anchored in his prostate cancer experience, but the book has found readers across various diagnoses.
Does the audiobook include the appendices with research studies mentioned in reviews?
Reviewers reference appendices covering fenbendazole and ivermectin research. Whether these are fully rendered in audio or provided as supplemental PDF material would be worth confirming before purchase if the reference section is a priority for you.
